AGIO — AGIOS PHARMACEUTICALS INC

Ownership history in OMERS ADMINISTRATION Corp  ·  3 quarters on record

This page tracks every 13F SEC filing in which OMERS ADMINISTRATION Corp reported a position in AGIOS PHARMACEUTICALS INC (AGIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2016 Q3)
Avg. % of fund
0.0%
First filed
2016 Q2
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 11,200 +5,800 +107.4% 0.00% $450K $40.14
2016 Q3 ADDED 5,400 +400 +8.0% 0.01% $285K $52.82
2016 Q2 INITIATED 5,000 — — 0.00% $209K $41.90
% of Fund (quarterly)    AGIO price (monthly, adj. close)

Other funds also holding AGIO

As of 2025 Q4 — sorted by position size

MPM BioImpact LLC 3Y 4.06% Exome Asset Management LLC 1.78% Rock Springs Capital Management LP 3Y 7Y 1.12% TCG Crossover Management, LLC 3Y 1.06% HighVista Strategies LLC 3Y 7Y 1.04% ARMISTICE CAPITAL, LLC 3Y 7Y 0.98% ARMISTICE CAPITAL, LLC 3Y 7Y 0.97% Frazier Life Sciences Management, L.P. 3Y 0.94% Tetragon Partners GP Ltd 3Y 7Y 0.93% Palo Alto Investors LP 3Y 7Y 0.81%
← Back to OMERS ADMINISTRATION Corp Holdings